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The loss of hippocampal interneurons has been considered as one reason for the onset of
temporal lobe epilepsy (TLE) by shifting the excitation-inhibition balance.Yet, there aremany
different interneuron types which show differential vulnerability in the context of an epilep-
togenic insult. We used the intrahippocampal kainate (KA) mouse model for TLE in which
a focal, unilateral KA injection induces status epilepticus (SE) followed by development of
granule cell dispersion (GCD) and hippocampal sclerosis surrounding the injection site but
not in the intermediate and temporal hippocampus. In this study, we characterized the loss
of interneurons with respect to septotemporal position and to differential vulnerability of
interneuron populations. To this end, we performed intrahippocampal recordings of the
initial SE, in situ hybridization for glutamic acid decarboxylase 67 (GAD67) mRNA and
immunohistochemistry for parvalbumin (PV) and neuropeptideY (NPY) in the early phase of
epileptogenesis at 2 days and at 21 days after KA injection, when recurrent epileptic activity
and GCD have fully developed.We show that SE extended along the entire septotemporal
axis of both hippocampi, but was stronger at distant sites than at the injection site. There
was an almost complete loss of interneurons surrounding the injection site and expanding
to the intermediate hippocampus already at 2 days but increasing until 21 days after KA.
Furthermore, we observed differential vulnerability of PV- and NPY-expressing cells: while
the latter were lost at the injection site but preserved at intermediate sites, PV-expressing
cells were gone even at sites more temporal than GCD. In addition, we found upregulation
of GAD67 mRNA expression in dispersed granule cells and of NPY staining in ipsilateral
granule cells and ipsi- and contralateral mossy ﬁbers. Our data thus indicate differential
survival capacity of interneurons in the epileptic hippocampus and compensatory plasticity
mechanisms depending on the hippocampal position.
Keywords: kainate injection, glutamic acid decarboxylase, parvalbumin, neuropeptide Y, temporal lobe epilepsy,
septotemporal axis
INTRODUCTION
Interneurons play a crucial role in balancing neuronal activity in
the brain. In epilepsy the loss of inhibitory interneurons has been
associated with the emergence of epileptic seizures (for review,
see Lopes da Silva et al., 1994; Olsen and Avoli, 1997; Fritschy,
2008). In temporal lobe epilepsy (TLE) interneurons show dif-
ferential vulnerability to an epileptogenic insult (Bouilleret et al.,
2000a,b; Magloczky and Freund, 2005; Kuruba et al., 2011) char-
acteristic for their particular expression pattern of interneuron
markers: interneurons commonly express glutamic acid decar-
boxylase (GAD), the key enzyme for synthesis of the inhibitory
transmitter gamma-aminobutyric acid (GABA; Ribak et al., 1978;
Freund and Buzsaki, 1996), but they can be differentiated accord-
ing to the selective expression of calcium-binding proteins [cal-
bindin, parvalbumin (PV), calretinin] and/or co-transmitters
[e.g., somatostatin, neuropeptide Y (NPY), cholecystokinin]
(Freund and Buzsaki, 1996).
Among the most vulnerable interneurons in human TLE and
in animal models for TLE are those expressing PV (Bouilleret
et al., 2000a; Kuruba et al., 2011) which comprise basket cells,
axo-axonic cells and bistratiﬁed cells (Freund and Buzsaki, 1996;
Somogyi and Klausberger, 2005). However, there are contro-
versial reports in the literature ranging from substantial loss
of PV-expressing cells (Bouilleret et al., 2000a), to a transient
loss of PV expression (Sloviter et al., 1991; Wittner et al., 2001)
or only marginal reduction of PV-expressing cells (Wyeth et al.,
2010), depending on the hippocampal region, the degree of
hippocampal sclerosis and the particular patient or animal
model.
Another interneuron population which is partially lost in TLE
expresses the co-transmitter NPY (Sloviter and Lowenstein, 1992;
Sperk et al., 1992; Kuruba et al., 2011). In the healthy hippocam-
pus the majority of these cells is positioned in the hilus (Deller
and Leranth, 1990; Sperk et al., 2007) and in stratum oriens of CA3
and CA1 (Freund and Buzsaki, 1996). In addition to the loss of
NPY-expressing cells in TLE, the upregulation of NPY in granule
cells and mossy ﬁbers has been described in several animal mod-
els (Sperk et al., 1992; Makiura et al., 1999; Vezzani et al., 1999;
Arabadzisz et al., 2005), most likely reﬂecting a compensatory
mechanism.
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Vulnerability of interneurons has also been described in the
intrahippocampal kainate (KA) mouse model for TLE, which
shows histological changes closely resembling human TLE includ-
ing hippocampal sclerosis and granule cell dispersion (GCD;
Suzuki et al., 1995; Bouilleret et al., 1999; Riban et al., 2002). Most
investigations in this model focused on the septal hippocam-
pus (close to the injection site) as it shows prominent cell loss
and strong GCD, however, our previous study revealed that sta-
tus epilepticus (SE) and recurrent epileptiform activity involve
the whole septotemporal extent of both hippocampi (Häussler
et al., 2012). This indicates that structural changes in the net-
work beyond the septal hippocampus are highly likely. Indeed,
we described that the intermediate hippocampus constitutes a
transition zone where GCD reduces to normal width, but where
neurogenesis, which is lost in the septal hippocampus (Heinrich
et al., 2006), is even increased compared to controls (Häussler
et al., 2012). It is, however, still unknown whether and how the
interneuron network is affected in this area – this might be crucial
for network balance and seizure generation.
To address this question, we investigated whether there is
a location-dependent vulnerability of interneurons along the
whole septotemporal axis of both hippocampi early and late
after KA injection. We present quantitative data showing a sub-
stantial loss of GAD-expressing interneurons beyond the area
where GCD occurred, with differential vulnerability of PV- and
NPY-expressing interneurons. In addition, NPY was upregulated
in granule cells and mossy ﬁbers in a time- and position-
dependent manner most likely reﬂecting particular compensatory
mechanisms at different septotemporal sites.
MATERIALS AND METHODS
ANIMALS
Experiments were carried out with adult (8–10 weeks) male
C57Bl/6N mice (Charles River, Sulzfeld, Germany). Mice were
kept in a 12 h light/dark cycle at room temperature (RT; 22 ± 1◦C)
with food andwater ad libitum. All animal procedureswere carried
out in accordance with the guidelines of the European Commu-
nity’s Council Directive of 22 September 2010 (2010/63/EU) and
approved by the regional council.
KAINATE INJECTION AND ELECTRODE IMPLANTATION
Unilateral, intrahippocampal KA injections were performed as
previously described (Heinrich et al., 2006; Häussler et al., 2012).
In brief, mice were anesthetized (100 mg/kg ketamine hydrochlo-
ride, 5 mg/kg xylazine, and 0.1 mg/kg atropine; i.p.) and placed
into a stereotaxic frame (David Kopf Instruments, Tujunga, CA,
USA) in ﬂat skull position. 50 nl (1 nmol) of a 20 mM KA solution
(Tocris, Bristol, UK) in 0.9% sterile NaCl solution were injected
into the right dorsal hippocampus within 1min [coordinates from
bregma (in mm): anterio-posterior (AP) = −2.0, medio-lateral
(ML) = −1.4, dorso-ventral (DV) = −1.9]. After injection, some
mice were immediately implanted with custom-made platinum-
iridium wire electrodes (Ø = 125 μm, Teﬂon insulated, World
Precision Instruments, Sarasota, FL, USA) at four positions along
the septotemporal axis of the ipsilateral and at one position in the
contralateral hippocampus [coordinates (in mm): (1) AP = −2.0,
ML = −1.4, DV = −1.9; (2) AP = −2.8, ML = −2.0, DV = −2.0;
(3) AP = −3.4, ML = −2.75, DV = −2.75, (4) AP = −3.8,
ML = −2.5, DV = −4.0, (contra) AP = −2.0, ML = +1.4,
DV = −1.9]. Stainless steel jeweler’s screws positioned in the skull
above the prefrontal cortex served as ground and reference. Elec-
trodeswere ﬁxed to the skull with cyanoacrylate and dental cement
and soldered to a connector which was permanently mounted on
the skull with dental cement. After recovery from anesthesia, mice
with implanted electrodes were recorded for several hours tomon-
itor SE.Mice, destined for histological analyses were not implanted
with electrodes to ensure better preservation of the tissue, but it
was ensured that behavioral manifestation of SE was comparable
to the recorded group.
IN VIVO INTRAHIPPOCAMPAL RECORDINGS
For recordings of hippocampal local ﬁeld potential (LFP) activity
in vivo, mice were connected to a miniature preampliﬁer [Multi
Channel Systems (MCS), Reutlingen, Germany]. Signals were
ampliﬁed (1000-fold, band-pass 1 Hz–5 kHz; MCS) and digitized
(sampling rate 10 kHz, Power1401 analog-to-digital (A/D) con-
verter, Spike2 software, Cambridge Electronic Design, Cambridge,
UK). Animals were recorded during the initial SE and at 3 and
21 days after KA injection to ensure that they developed chronic
TLE. Electrode positions were veriﬁed in Nissl-stained sections as
described previously (Häussler et al., 2012).
PERFUSION AND TISSUE PREPARATION
Mice were deeply anesthetized at 2 and 21 days after KA injection
and transcardially perfused with 0.9% NaCl solution followed by
paraformaldehyde [PFA, 4% in 0.1 M phosphate buffer (PB), pH
7.4]. The brains were post-ﬁxed in the same ﬁxative for 4 h at 4◦C,
and either cryoprotected (20% sucrose, overnight, 4◦C), frozen in
isopentane and sectioned with a cryostat (50 μm, coronal plane)
or transferred into PB and cut on a vibratome (Leica, VT1000S,
Bensheim, Germany; 50 μm, coronal plane).
IMMUNOCYTOCHEMISTRY
For immunocytochemistry, sections were processed using a free-
ﬂoating procedure. Theywere preincubated in 0.25%TritonX-100
and 10% normal serum in PB for 30 min and incubated with
the primary antibody (4 h at RT + overnight at 4◦C). The fol-
lowing primary antibodies were used: rabbit anti-PV (1:2500,
Swant, Bellinzona, Switzerland), rabbit anti-NPY (1:3000, Abcam,
Cambridge,UK), rabbit anti-GAD65/67 (GAD65/67, 1:4000,Mil-
lipore, Temecula, CA,USA). Secondary antibodies were coupled to
CyTM2 (1:200) or CyTM3 (1:400, Jackson ImmunoResearch Labo-
ratories,WestGrove, PA,USA) and counterstainingwasperformed
with 4′,6-diamidino-2-phenylindole (DAPI, 1:10000) in the dark
for 2–3 h at RT. Sections were coverslipped with anti-fading
mounting medium (IMMU-Mount, ThermoShandon, Dreieich,
Germany).
IN SITU HYBRIDIZATION
Glutamic acid decarboxylase 67 mRNA was localized by in situ
hybridization (ISH) with digoxigenin (DIG)-labeled cRNA probes
generated by in vitro transcription as described earlier (Kulik
et al., 2003). Cryostat sections were pretreated in hybridization
buffer (50% formamide, 4× SSC (1× SSC = 0.15 M NaCl,
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0.015 M sodium citrate, pH 7.0), 50 mM NaH2PO4, 250 μg/ml
heat-denatured salmon sperm DNA, 100 μg/ml tRNA, 5% dex-
transulfate and 1%Denhardt’s solution) dilutedwith 2× SSC (1:1)
for 15 min and prehybridized in hybridization buffer for 60 min at
45◦C. Hybridization was performed in the same buffer including
DIG-labeled GAD67 anti-sense or sense cRNA probes (50 ng/ml)
at 45◦C overnight. After hybridization, the brain sections were
washed in 2× SSC (2 × 15 min, RT), 2× SSC and 50% for-
mamide (15 min, 55◦C), 0.1× SSC and 50% formamide (15 min
at 55◦C), 0.1× SSC (2 × 15 min, 55◦C) and ﬁnally in Tris-buffered
saline (TBS, 2 × 10 min, RT). Blocking was performed in blocking
buffer (1% blocking reagent in TBS, 60 min, RT). Immunolog-
ical detection of DIG-labeled hybrids was performed with an
anti-DIG antibody conjugated with alkaline phosphatase (1:1500,
raised in sheep, Roche, Mannheim, Germany) following standard
protocols. Sections were coverslipped in Kaiser’s glycerol gelatine.
FLUORO-JADE B STAINING
The success of KA injections was monitored by Nissl (data
not shown) or Fluoro-Jade B stainings to monitor cell death.
Sections were mounted on gelatine-coated microscope slides,
air-dried and transferred into 0.06% potassium permanganate
solution (15 min), followed by 0.0004% Fluoro-Jade B solution
(30 min). Sections were cleared in xylene and coverslipped with
Hypermount.
MICROSCOPY AND COUNTING PROCEDURES
Histological sections were analyzed with a microscope equipped
with appropriate ﬂuorescence ﬁlters (Axioplan 2, Zeiss, Göt-
tingen, Germany), photomicrographs were taken with a digital
camera and processed with Axiovision software (Zeiss). Identi-
cal exposure times were used for sections that were compared.
ISH sections were analyzed using brightﬁeld microscopy with
the same equipment. In the photomicrographs of ISH sections,
GAD67 mRNA-positive cells were counted using ImageJ software
(National Institutes of Health, Bethesda, Maryland, USA) with
the integrated Cell Counter plugin. For quantiﬁcations, repre-
sentative coronal sections were selected at four positions along
the septotemporal axis according to the following positions given
in the Allen Mouse Brain Atlas (©2012 Allen Institute for Brain
Science: http://mouse.brain-map.org): AP relative to bregma (in
mm); (1): −1.35, (2): −2.15, (3): −2.98, (4): −3.55. As regions
of interest (ROI) we marked the hilus or the complete hippocam-
pus in each section, respectively. Only mice for which sections at
each of these positions from the ipsilateral and contralateral hip-
pocampuswere available were used for quantiﬁcation. To compare
densities of GAD67 mRNA-positive cells in epileptic and con-
trol mice at these particular positions, all GAD67 mRNA-positive
interneurons within each ROI were manually marked, counted
and the density was calculated using the area of the ROI (values
are given in cells/mm2). The densities were then averaged across
animals for each position. The same method was applied to quan-
tify PV-positive interneurons in immunocytochemically stained
sections.
For densitometric analysis of Fluoro-Jade B-positive cells
images with equal illumination were taken and the same threshold
was applied for every image. The total area of the hippocampus
was divided by the area of pixels with brightness exceeding thresh-
old resulting in the relative area of positive pixels as a measure for
the amount of cell death.
DATA ANALYSIS
For visualization of different densities of GAD67 mRNA-positive
cells in all hippocampal areas, a custom-made C# program
(Microsoft®Visual StudioProfessional 2010,Redmond,WA,USA)
was developed to create heatmap images in false-color along
the septotemporal axis. Images from representative ISH-stained
sections were selected for each of the four positions for controls
and 2 and 21 days after KA. Using the GAD67 mRNA-positive cells
marked in ImageJ, where the position of each marked cell deﬁnes
an x- and y-coordinate in a coordinate system, a basic matrix
was placed centrally onto the position of each cell. The matrix
consisted of radially decreasing intensity values (radius 100 pix-
els in the original image, values linearly decreasing from 100 in
the center to 0 in the periphery). Overlapping basic matrix values
of different cells were summed resulting in high intensity values
where cells were located close to each other. To allow comparison,
the values were normalized to the maximal intensity value for each
septotemporal position. Finally, the matrices were transferred into
grayscale (i.e., scaled to values between 0 and 255) and allocated
to a new RGB color space (gray indicates no cells, red indicates
highest cell density).
STATISTICAL ANALYSIS
For all values, mean and standard error of the mean (SEM) are
given. Statistical comparison was made with a one-way analysis
of variance (ANOVA) followed by Tukey’s multiple comparison
test. Signiﬁcance thresholds were as follows: *p< 0.05, **p< 0.01,
***p < 0.001. Statistical analysis was performed with GraphPad
Prism version 5.01 (GraphPad Software, San Diego, CA, USA).
RESULTS
STATUS EPILEPTICUS IS FOLLOWED BY EXTENSIVE CELL DEATH
To monitor SE, a series of mice was implanted with hippocampal
electrodes and LFPs were recorded for 2–3 h after mice had awak-
ened from anesthesia. SE activity, consisting of a repetitive pattern
of high amplitude population spikes and spike-and-wave dis-
charges with intermittent short depression periods, was recorded
at all septotemporal positions of the ipsilateral hippocampus and
in the contralateral hippocampus. At the time point of recording,
amplitudes were largest in the ipsilateral intermediate and the con-
tralateral hippocampus in all mice (n = 6,Figures 1A,B). This is in
accordance with our previous study (Häussler et al., 2012), where
quantiﬁcation revealed a signiﬁcant increase in power in the theta
band (3–8 Hz) in the intermediate, temporal and contralateral
hippocampus during SE. Simultaneous with pathophysiological
activity, mice showed behavioral SE, including rotations, chew-
ing or convulsive movements of the forelimbs, alternating with
immobility. This pattern continuously persisted for 6–10 h after
KA injection and subsided spontaneously.
One day after KA injection prominent cell death occurred
mainly close to the injection site in CA1, CA3 and the hilus of
the ipsilateral hippocampus, as shown by Fluoro-Jade B stainings
(n = 5, Figures 2B,D,E). The contralateral hippocampus was
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FIGURE 1 | Representative LFP recording during status epilepticus
(SE). (A, B) LFPs were recorded at 4 positions (1: most septal, 4: most
temporal) in the ipsilateral and at one position in the contralateral (c)
hippocampus (for illustration of electrode positions see schematic brain
drawing) starting from ∼2 h after awakening from surgery. SE was
characterized by a repetitive pattern of spike-and-wave discharges with
short intermittent depression periods, accompanied by behavioral signs
such as convulsive movements, rotation or immobility. (B) Enlargement of
(A). SE activity was strongest in the intermediate and contralateral
hippocampus at this time point.
devoid of cell loss (Figures 2A,C) or a group of dying cells was
observed in distal CA1 (3/5 mice). Ipsilateral cell loss follow-
ing focal KA injection extended to the intermediate hippocampus
(Figure 2D) but the temporal hippocampus was unaffected. Den-
sitometric analysis revealed prominent differences between cell
loss in the ipsilateral and contralateral hippocampus, which, how-
ever, only were signiﬁcant at position 2 (Figure 2F; ANOVA:
p < 0.001, Tukey’s post-test: p < 0.001), most likely due to vari-
able extent of cell death mainly in CA1 across mice. In addition
to strong cell loss in the pyramidal cell layer in CA3 and CA1
and hilar mossy cells, Fluoro-Jade B-positive cells were also posi-
tioned in strata radiatum and oriens of CA3 and CA1 (Figure 2B)
and in the inner and outer portion of the dentate granule cell
layer (Figure 2E). These positions are usually associated with
interneurons.
POSITION-DEPENDENT LOSS OF GAD67 MRNA-EXPRESSING
INTERNEURONS IN THE EPILEPTIC MOUSE HIPPOCAMPUS
Glutamic acid decarboxylase 67 is expressed in nearly all GABAer-
gic interneurons (Freund and Buzsaki, 1996). To monitor the dis-
tribution of hippocampal interneurons along the septotemporal
axis after focal KA injection into the septal hippocampus, we
FIGURE 2 | Status epilepticus is followed by prominent neuronal
death in the septal ipsilateral hippocampus. (A–E) Representative
Fluoro-Jade B-stained sections of a KA-injected mouse at one day after
KA injection to monitor neuronal degeneration. (A, C) The contralateral
hippocampus was devoid of any cell death in the septal (A) and
intermediate and temporal hippocampus (C). (B) In the ipsilateral
hippocampus prominent Fluoro-Jade B staining occurred in the pyramidal
cell layer of CA3 and CA1 and in the hilus, but single Fluoro-Jade
B-positive cells were also located in strata oriens and radiatum of CA3
and CA1 and in the inner and outer portion of the granule cell layer. An
enlargement of the hilus and granule cell layer, displaying the shape of
Fluoro-Jade B-positive cells is shown in (E). (D) Fluoro-Jade B-positive
cells were also visible in the intermediate hippocampus but the temporal
hippocampus was devoid of dying cells. The arrow marks the most
temporally located Fluoro-Jade B-positive cell group. (F) Densitometric
analysis of Fluoro-Jade B-positive areas relative to the area of the whole
hippocampus in the same section at four positions along the
septotemporal axis (see scheme in Figure 1) in the ipsilateral and
contralateral hippocampus. Values are displayed as mean ± SEM. A
signiﬁcant difference was observed at position 2 (n = 5, p < 0.001,
ANOVA, ***p < 0.001 Tukey’s post-test). Scale bars: A–D, 100 μm; E,
50 μm. GCL, granule cell layer; H, hilus; CA1, CA2, CA3, cornu ammonis;
I1, ipsilateral position 1; C1, contralateral position 1.
performed ISH for GAD67 mRNA expression at 2 and 21 days
after injection.
In control mice GAD67 mRNA-expressing interneurons were
distributed in all hippocampal areas but accumulated in or close to
the pyramidal cell layer, the granule cell layer and in the hilus at all
septotemporal positions (controls: n = 7 mice, Figures 3A–D).
The increased density of GAD67 mRNA-positive cells in the
temporal hippocampus (Figure 3D) matches previous studies
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FIGURE 3 | Continued
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FIGURE 3 | Continued
Septotemporal distribution and quantification of GAD67 mRNA
expressing neurons at 2 and 21 days after KA injection. In situ
hybridization for GAD67 mRNA was performed as described in Section
“Materials and Methods.” Representative coronal sections of four
septotemporal levels are shown. (A–D) Control mouse, septal (A, B),
intermediate (C) and temporal (D) hippocampus. GAD67 mRNA-expressing
cells were distributed throughout the hippocampus but accumulated close
to the granule cell layer and pyramidal cell layer. This pattern was
comparable at all septotemporal levels. Granule cells in the dentate gyrus
show weak GAD67 mRNA expression. (E–H) Contralateral hippocampus,
2 days after KA injection, septal (E, F), intermediate (G) and temporal level
(H). The distribution and density of GAD67 mRNA-positive cells was
comparable to controls at all septotemporal levels. In some mice GAD67
mRNA-positive cells were slightly reduced in distal CA1 of the septal
hippocampus (E). GAD67 mRNA expression in granule cells was
comparable to controls or slightly upregulated in the septal hippocampus
only. (I–L) Ipsilateral hippocampus, 2 days after KA injection. (I, J) In the
septal hippocampus most GAD67 mRNA-expressing cells were lost except
for a group of cells in CA3/CA2 (arrow). GAD67 mRNA expression in granule
cells was upregulated. (K) In the more dorsal part of the intermediate
hippocampus GAD67 mRNA-expressing interneurons were lost, whereas in
the more ventral parts they were preserved. GAD67 mRNA expression in
granule cells was upregulated. (L) In the temporal hippocampus GAD67
mRNA-expressing interneurons were only lost in the very dorsal parts of the
section but preserved elsewhere, GAD67 mRNA expression in granule cells
was comparable to controls. (M–P) Ipsilateral hippocampus, 21 days after
KA injection. (M, N) In the septal hippocampus only a few GAD67
mRNA-expressing cells were preserved. Note that cells in CA3, which were
present earlier, were lost at the late time point indicating a progressive
interneuron loss. The apparent reduction of GAD67 mRNA upregulation in
granule cells is most likely due to their reduced density owing to the
prominent dispersion of the granule cell layer. (O) In the intermediate
hippocampus GAD67 mRNA-expressing cells were lost to a larger extent
than at 2 days after KA and GAD67 mRNA expression in the granule cells
was still strongly increased. (P) In the temporal hippocampus, GAD67
mRNA-expressing interneurons were lost in the dorsal part of the section
indicating the progressive loss of interneurons. GAD67 mRNA was
upregulated only in dispersed granule cells (arrow marks the transition
zone). In the ventral parts of the section GAD67 mRNA expression was
comparable to controls. (Q) Quantiﬁcation of GAD67 mRNA-expressing
cells at four positions along the septotemporal axis in controls and at 2 and
21 days after KA. Cells were counted in the whole hippocampus and cell
density is given as GAD67-positive cells/mm2(n = 5 each group). Values are
displayed as mean ± SEM, statistical comparison was made with an
ANOVA andTukey’s multiple comparison test, signiﬁcance values were set
as follows: *p < 0.05, **p < 0.01, ***p < 0.001. (R) As in (Q), but only the
hilus was marked as region of interest. Note that differences at position
three are only signiﬁcant when only the area of the hilus is considered. (S)
Enlargement of the transition zone, see box marked in (P). A few GAD67
mRNA-positive cells appeared dorsal to the transition zone (arrows) but the
full density of GAD67 mRNA-positive cells was only restored ventral to this
area. Note that GAD67 mRNA upregulation affected only dispersed granule
cells. (T) Quantiﬁcation of GAD67 mRNA-expressing cells only in the areas
of the hippocampus where GCD was present at 21 days (in contrast to (Q),
where the whole hippocampus was considered). The loss was only
signiﬁcant at 21 days, indicating the progressive loss of interneurons in the
temporal hippocampus (p = 0.015, ANOVA, p < 0.05, Tukey’s post-test,
n = 5 each group). (U) Same as in T but only for the area of the hilus
(p = 0.008, ANOVA, p < 0.01, Tukey’s post-test, n = 5 each group). Scale
bars: 200 μm, S: 50 μm. GCL, granule cell layer; H, hilus; CA1, CA2, CA3,
cornu ammonis.
analyzing the septotemporal interneuron distribution in healthy
mice (Jinno et al., 1998), but quantiﬁcation revealed that the den-
sity of positive cells did not differ signiﬁcantly from more anterior
levels (Figures 3Q,R). GAD67 mRNA was also weakly expressed
in granule cells of control mice, as described earlier in mice and
rats (Schwarzer and Sperk, 1995; Sloviter et al., 1996).
In the contralateral hippocampus of KA-injected mice the
distribution of GAD67 mRNA-positive cells was comparable to
controls at all septotemporal levels at 2 days (Figures 3E–H)
and 21 days after KA (data not shown), except for a small
reduction in density in distal CA1 of the septal hippocam-
pus in some mice. Quantiﬁcation revealed that the number
of GAD67 mRNA-expressing cells was comparable to controls
at all septotemporal levels (Figures 3Q,R). GAD67 mRNA
expression in granule cells was comparable to controls or only
slightly upregulated in the septal hippocampus (Figures 3E,F)
but unchanged in the intermediate and temporal hippocampus
(Figures 3G,H).
In contrast, already at 2 days after KA injection, GAD67 mRNA
expression was almost completely lost in the ipsilateral septal
hippocampus, except for a group of interneurons clustered in
CA3a/CA2 and a few scattered cells in the dentate gyrus (KA
2 days: n = 7 mice; Figures 3I,J). Quantiﬁcation of GAD67
mRNA-positive cell bodies revealed a signiﬁcant reduction of
cell density in the ipsilateral septal hippocampus compared to
controls and to the contralateral hippocampus (n = 5 for each
group; position 1: ANOVA: p = 0.024, pairwise Tukey’s post-test:
ipsilateral-control p < 0.001, ipsilateral-contralateral p < 0.01;
position 2: ANOVA: p < 0.0001, pairwise: ipsilateral-control
p < 0.001, ipsilateral-contralateral p < 0.001; Figure 3Q). In
the intermediate hippocampus GAD67 mRNA-expressing cells
were only partially lost in the dorsal parts of the section but
preserved in ventral parts (Figure 3K). In the temporal hip-
pocampus they were mostly preserved at 2 days after KA injection
(Figure 3L). No signiﬁcant differences in cell density of GAD67
mRNA-positive cells were observed in the intermediate and tem-
poral hippocampus when we considered the area of the whole
hippocampus for quantiﬁcation (position 3: ANOVA: p = 0.55;
position 4: ANOVA: p = 0.32; Figure 3Q). When consider-
ing only the area of the hilus, we found a signiﬁcant reduction
of interneuron density compared to controls and to the con-
tralateral side at the level of the septal and the intermediate
hippocampus but not at temporal sites (n = 5 each group;
position 1: ANOVA: p < 0.0001, pairwise Tukey’s post-test:
ipsilateral-control and ipsilateral-contralateral p < 0.01; position
2:ANOVA:p=0.0005, pairwise: ipsilateral-control and ipsilateral-
contralateral p< 0.001, position 3: ANOVA: p = 0.0018, pairwise:
ipsilateral-control and ipsilateral-contralateral p < 0.01; position
4: ANOVA: p = 0.036, pairwise: not signiﬁcant; Figure 3R). Con-
comitant with the loss of interneurons, we observed a strong
upregulation of GAD67 mRNA expression in ipsilateral gran-
ule cells at all positions except for the temporal hippocampus
(Figures 3I–L), which is in agreement with studies in rats
(Schwarzer and Sperk, 1995), but in contrast to Makiura et al.
(1999) who showed a transient increase of GABA but not of
GAD67.
In the chronic phase at 21 days after KA injection, when
GCD and recurrent epileptic activity had fully developed, GAD67
mRNA expression was even further decreased: in the septal
hippocampus a few GAD67 mRNA-expressing cells remained
in the dentate gyrus but GAD67 mRNA-expressing interneu-
rons in CA3a/CA2 were lost at this time point (KA 21 days:
n = 5 mice, Figures 3M,N). The reduction of interneurons in
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the septal hippocampus was signiﬁcant compared to the con-
tralateral hippocampus and controls (position 1 and 2: pairwise
Tukey’s post-test: ipsilateral-control and ipsilateral-contralateral
p< 0.001) but the further reduction compared to 2 days after KA
injection did not reach signiﬁcance (Figure 3Q). At this late time
point, cell loss progressed further toward the temporal hippocam-
pus (Figures 3O,P), however, due to the large septotemporal extent
of coronal slices at position 3 and 4, this was only signiﬁcant
in the intermediate hilus (position 3: pairwise Tukey’s post-
test: ipsilateral-control and ipsilateral-contralateral p < 0.001;
Figures 3Q,R). Notably, when comparing the septotemporal
extent of GCD and interneuron loss, we observed that GAD67
mRNA-positive interneurons were mostly lost at sites where GCD
was present and their full density was only established tempo-
ral to the transition zone from GCD to normal granule cell layer
width (Figures 3S–U). Theupregulationof GAD67mRNAexpres-
sion in granule cells was still visible at 21 days but interestingly
only in dispersed granule cells (Figure 3P). Immunocytochem-
ical analysis with an antibody against GAD65/67 conﬁrmed the
region-selective loss of GAD65/67-expressing interneurons and
upregulation of GAD65/67 in granule cells in the septal and inter-
mediate, but not temporal hippocampus on the protein level (data
not shown). In addition, it revealed a strong upregulation of
GAD65/67 expression in ipsilateral mossy ﬁber terminals in the
hilus and CA3 at 2 days after KA and throughout the granule cell
layer,molecular layer andCA3 at 21 days after KA, reﬂectingmossy
ﬁber sprouting.
For visualization of the distribution of GAD67 mRNA-
expressing interneurons we generated heatmaps which display
the cell density in false color (Figure 4). These maps illustrate
the progressive loss of GAD67 mRNA expression between 2 and
21 days in the intermediate and temporal hippocampus (posi-
tions 3 and 4, Figures 4G,H,K,L). Furthermore, they show that
reduced interneuron density extended to more temporal sites than
GCD (Figures 4K,L), indicating the high sensitivity of GABAergic
interneurons to KA injection and SE.
PARVALBUMIN-POSITIVE INTERNEURONS ARE REDUCED BEYOND THE
TRANSITION ZONE
To more speciﬁcally characterize the loss of interneurons along
the septotemporal axis, we immunocytochemically stained PV-
expressing interneurons since they are highly vulnerable in KA-
injected mice surrounding the injection site (Bouilleret et al.,
2000a). In controls, the majority of PV-expressing cells were
located close to or within the principal cell layers (controls: n = 6
mice, Figure 5A), representing most likely axo-axonic and bas-
ket cells. A few PV-positive interneurons were also located in
the hilus and strata radiatum and oriens of the CA region. The
distribution of PV-positive cells was comparable at all septotem-
poral sites (Figures 5A–C), whichwas conﬁrmed by quantiﬁcation
(Figures 5O,P) and matched previous results (Kosaka et al., 1987;
Somogyi and Klausberger, 2005). In the contralateral hippocam-
pus of KA-injected mice the density of PV-expressing cells was
comparable to controls at all sites (Figures 5O,P). Due to the
high similarity of positions 1 and 2, as shown for GAD67
mRNA expression, we only display positions 2–4 in the following
photomicrographs.
Already at 2 days after KA injection PV-positive cell bodies were
strongly reduced in the septal hippocampus except for a few cells
in CA3 and distal CA1 (KA 2 days: n = 4 mice, Figures 5D,E). The
PV-positive axon plexus in CA1 and in the inner molecular layer
was also vanishing (Figures 5D,F). The strong ﬂuorescence in the
pyramidal cell layer of CA1 is comparable to what can be observed
for many different antibodies and is most likely due to unspeciﬁc
staining of degenerating cells. Quantiﬁcation of PV-expressing
interneurons revealed that the loss of these cells was signiﬁcant
compared to controls and the contralateral hippocampus for the
hilus (n = 6 controls, n = 4 KA-injected mice; position 1: ANOVA:
p = 0.0011, pairwise Tukey’s post-test: ipsilateral-control p< 0.05;
position 2: ANOVA: p < 0.0001, pairwise: ipsilateral-control
and ipsilateral-contralateral p < 0.001) as well as the whole hip-
pocampus (position 1: ANOVA: p = 0.0002, pairwise: ipsilateral-
contralateral p < 0.05; position 2: ANOVA: p < 0.0001, pairwise:
ipsilateral-control p< 0.001 and ipsilateral-contralateral p< 0.01;
Figures 5O,P).
In the intermediate hippocampus a characteristic pattern was
observable: In the dorsal part the reduction of PV-positive cell
bodies and partial preservation of the PV-positive plexuswas com-
parable to the septal hippocampus (Figures 5G–I), while in the
ventral part PV-positive cell bodies and their axon plexus seemed
preserved (Figures 5G,J,K). This was conﬁrmed by quantiﬁca-
tion which revealed a signiﬁcant loss of PV-expressing cells in
the hilus (position 3: ANOVA: p = 0.0013; pairwise: ipsilateral-
contralateral and ipsilateral-contralateral p< 0.05) but no changes
when the whole hippocampus was regarded (ANOVA: p = 0.30;
Figures 5O,P). In the temporal hippocampus PV-positive cells
and axons were only lost in the very dorsal parts of the section but
preserved elsewhere (Figures 5L–N) and quantiﬁcation showed
comparable densities for the hilus (position 4: ANOVA: p = 0.10)
and hippocampus (ANOVA: p = 0.02, pairwise: not signiﬁcant;
Figures 5O,P).
At 21 days after KA,PV-expressing cells in the septal hippocam-
pus were nearly completely lost except for a very small group of
dysmorphic neurons in CA3 (Figures 6A,B); furthermore, the
PV-stained axon plexus in CA1 and the dentate gyrus was no
longer visible (KA 21 days: n = 5 mice, Figure 6A). This reduction
was signiﬁcant when regarding the whole hippocampus (position
1: pairwise Tukey’s post-test: ipsilateral-control and ipsilateral-
contralateral p < 0.01; position 2: pairwise: ipsilateral-control
and ipsilateral-contralateral p < 0.001; Figure 5O) as well as the
hilus (position 1: pairwise: ipsilateral-control p < 0.01; position
2: pairwise: ipsilateral-control p < 0.001, ipsilateral-contralateral
p< 0.01; Figure 5P). In the intermediate hippocampus the loss of
PV-positive cells and axons also progressed to slightlymore ventral
areas (i.e., toward the temporal hippocampus) than at 2 days after
KA injection (Figure 6C). Yet, this difference was only signiﬁcant
for the hilus (position 3: pairwise: ipsilateral-control p< 0.01) but
not for the whole hippocampus (Figures 5O,P). At the most tem-
poral site (position 4), the progression of the loss of PV labeling
between 2 and 21 days after KA was also apparent, in particular
in the hilus (Figure 6D), however, this reduction was not signiﬁ-
cant (Figure 5P). Notably, PV-positive cell bodies were preserved
only at sites temporal to the transition zone from GCD to normal
granule cell layer width (Figures 6C,D).
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FIGURE 4 | Spatial distribution of GAD67 mRNA-positive interneurons.
(A–L) Density of GAD67 mRNA-expressing interneurons in representative
hippocampal sections along the septotemporal axis displayed as heatmaps
in false-color, relative to the maximal density within each position. The
outer border of the hippocampus and the hilus are marked with white
traces. Brighter color indicates higher, darker color lower relative cell
density. (A–D) Control mouse, septal (A, B), intermediate (C) and temporal
hippocampus (D). (E–H) Ipsilateral hippocampus, 2 days after KA injection,
septal (E, F), intermediate (G) and temporal level (H). A gradient of cell
loss along the septotemporal axis is visible. (I–L) Ipsilateral hippocampus,
21 days after KA injection, septal (I, J), intermediate (K) and temporal
level (L). Note that the loss of GAD67 mRNA-expressing cells extends
to further temporal areas than at 2 days after KA and the reduction
of interneuron density can be observed beyond the transition zone
from GCD to normal granule cell layer width (L, arrows). Scale bars:
200 μm.
REDUCTION OF NPY-POSITIVE INTERNEURONS, BUT
LOCATION-DEPENDENT UPREGULATION OF NPY
IN MOSSY FIBERS AND GRANULE CELLS
In controls, NPY-positive cells were abundant in the hilus and
many NPY-expressing cell bodies were visible in stratum oriens
of CA3 and CA1 at all septotemporal levels (controls: n = 4
mice, Figures 7A–D), in line with previous reports in mice (Mak-
iura et al., 1999) and rats (Deller and Leranth, 1990; Sperk et al.,
2007; Kuruba et al., 2011). Some NPY-positive cells were present
in strata radiatum and pyramidale of CA3 and CA1. In addition,
a weakly stained NPY-positive axon plexus was visible throughout
the hippocampus (Figures 7A–D).
At 2 days after KA injection, the contralateral hippocam-
pus showed considerably enhanced NPY staining in cell bodies
mainly in strata oriens, pyramidale and radiatum of CA1 of the
septal hippocampus (n = 5 of 5 mice, Figures 7E,F) and in
dorsally located parts of the intermediate and temporal hippocam-
pus (4/5 mice, Figures 7G,H). In addition, NPY was slightly
(2/5 mice) or even strongly upregulated in contralateral mossy
ﬁbers at all septotemporal levels (3/5 mice, Figures 6E–H). This
upregulation spatially overlapped with NPY-positive interneu-
rons and did not allow reliable quantiﬁcation of NPY-positive
cells. NPY expression in granule cells was comparable to
controls.
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FIGURE 5 | Continued
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FIGURE 5 | Continued
Parvalbumin-positive cells are lost in the septal and intermediate
hippocampus at 2 days after KA injection. (A–N) Representative sections
of an immunocytochemical staining for PV. (A–C) Control mouse, septal (A),
intermediate (B), and temporal hippocampus (C). PV-positive cells were
mainly located in or close to the granule cell layer or the pyramidal cell layer
and in stratum oriens and were equally distributed along the septotemporal
axis. The PV-positive axon plexus surrounding the principal cell layers is
visible. (D–N) Ipsilateral hippocampus, 2 days after KA. (D–F) In the septal
hippocampus most PV-positive cells were lost, except for a few cells in CA3
(white box, enlarged in E, arrow marks PV-positive cell), and the PV-positive
axon plexus was reduced particularly in the dentate gyrus and disorganized
in CA1 (yellow box, enlarged in F). (G)The more dorsal areas of the
intermediate hippocampus showed a cell loss pattern in CA1 comparable to
the septal hippocampus (white arrow) whereas in the more ventral areas
PV-positive cells were preserved (yellow arrow). In the dorsal areas of the
dentate gyrus residual PV expression was observed close to the granule cell
layer (white box, enlarged in H and I; with DAPI to highlight the granule cell
layer). In the ventral areas of the intermediate dentate gyrus and in CA3
PV-expressing cells were preserved (yellow box, enlarged in J and K with
DAPI). (L) In the temporal hippocampus PV-expressing cells were only
reduced in the very dorsal parts of the section (arrow) but preserved
elsewhere (white box, enlarged in M and N with DAPI). (O) Quantiﬁcation
of PV-positive interneurons at four positions along the septotemporal axis in
controls and at 2 and 21 days after KA. Cells were counted in the whole
hippocampus and cell density is given as PV-positive cells/mm2.Values are
displayed as mean ± SEM (n = 6 controls, n = 4 KA 2 days, n = 5 KA
21 days), statistical comparison was made with an ANOVA andTukey’s
multiple comparison test, signiﬁcance values were set as follows:
*p < 0.05, **p < 0.01, ***p < 0.001. (P) As in (O), but only the hilus was
marked as region of interest. Note that at position two PV-positive cells in
the hilus were nearly completely lost after KA injection. Scale bars:A–D, G,
L, 200 μm; E, F, H–K, M, N, 100 μm.
In contrast, in the ipsilateral hippocampus, NPY-positive
interneurons were lost in the septal hilus and strongly reduced
in CA1, but mostly preserved in CA3 (KA 2 days: 5/5 mice,
Figures 7I,J). In the intermediate and temporal hippocampus
NPY-positive interneurons were preserved in the hilus and CA
region (Figures 7K,L). More conspicuous, however, was the strong
upregulation of NPY in septal granule cells and in dorsally located
granule cells of the intermediate hippocampus and in their den-
drites at 2 days after KA injection (5/5 mice, Figures 7I–K). In
addition, mossy ﬁbers showed a strongly increased NPY stain-
ing in the septal hippocampus (5/5 mice, Figures 7I,J), which
extended to the intermediate and temporal hippocampus (3/5
mice) or vanished in ventral parts of the intermediate and
temporal hippocampus (2/5 mice, Figures 7K,L).
At 21 days after KA, the upregulation of NPY expres-
sion in interneurons in the contralateral hippocampus was no
FIGURE 6 | Continued
FIGURE 6 | Progressive loss of parvalbumin-positive cells at 21 days
after KA injection. (A–D) Ipsilateral hippocampus, 21 days after KA. (A) In
the septal hippocampus not only the PV-positive cells but also the
PV-positive axon plexus almost completely vanished, indicating a
progressive loss. A few dysmorphic cells remained in CA3 in some slices
(white box, enlarged in B). Note the prominent GCD. (C) In the
intermediate hippocampus PV-positive cells and the PV-positive axon
plexus were lost in the dorsal part (white box, enlarged in inset with white
frame) but preserved at more ventral sites (yellow box, enlarged in inset
with yellow frame). The loss extended to more ventral areas than at 2 days
after KA. The transition zone from GCD to normal granule cell layer width is
marked (arrows). Note that the loss of PV-positive cells extends slightly
beyond this zone. (D) In the temporal hippocampus PV-expressing cells and
the PV-positive plexus were gone in the dorsal parts but preserved
elsewhere. The transition zone is marked with arrows. Scale bars:A, C, D,
200 μm; B, insets in C, 50 μm.
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FIGURE 7 | Ectopic pattern of NPY staining at 2 days after KA injection.
(A–L) Representative sections of immunocytochemical staining for NPY
(red) with DAPI counterstaining (blue) at 2 days after KA injection. (A–D)
Control mouse, septal (A, B), intermediate (C) and temporal hippocampus
(D). NPY-expressing cells were located mainly in the hilus and in stratum
oriens and their connections were visible throughout the hippocampus. (B)
Cutout of (A) with hilus and granule cell layer enlarged. NPY-positive cells
were mostly located in the hilus and their axons were visible throughout
the dentate gyrus but granule cells and mossy ﬁbers were not stained.
(E–H) Contralateral hippocampus. (E) In the septal hippocampus an
upregulation of NPY expression in interneurons was visible in the CA
region in strata oriens, pyramidale and radiatum. In addition, NPY was
strongly upregulated in the mossy ﬁbers. NPY-positive interneurons in the
hilus were preserved but mostly outshined by the strong mossy ﬁber
staining in the whole hilus (see enlarged in F). (G, H) In the intermediate
and temporal hippocampus staining of NPY-positive interneurons was
slightly upregulated in the dorsal part of the section but comparable to
controls in the ventral part. NPY expression in the mossy ﬁbers was
strongly increased in the hilus, CA3 and CA2 at all septotemporal levels.
(I–L) Ipsilateral hippocampus. (I) In the septal hippocampus NPY-expressing
interneurons were lost except for a few remaining, strongly stained cells in
CA3 stratum oriens. NPY expression was upregulated in the mossy ﬁbers.
In contrast to the contralateral side, NPY imunostaining was strongly
enhanced in a large portion of granule cell bodies and dendrites (see
enlarged in J, arrow). (K) In the intermediate hippocampus NPY-expressing
cells were preserved in the hilus and expression in the CA region was
comparable to controls. Upregulation of NPY in the mossy ﬁbers was only
visible in the very dorsal parts of the section. (L) In the temporal
hippocampus NPY expression was comparable to controls. Scale bars:
200 μm; B, F, J, insets 100 μm.
longer visible and staining of interneurons was comparable
to controls in all mice (n = 6, Figures 8A–E). In contrast,
the enhanced NPY labeling in mossy ﬁbers was maintained
at all septotemporal positions (Figures 8A–E), however, the
intensity of labeling was variable across mice (3/6 mice with
weak NPY upregulation, 3/6 mice with strong NPY upregu-
lation) in agreement with Arabadzisz et al. (2005). In addi-
tion, in the septal hippocampus NPY-positive terminals were
apparent in the inner molecular layer close to the granule cells
(Figure 8A).
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In the ipsilateral septal hippocampus the progressive loss of
NPY-positive cells was more pronounced than at 2 days after KA
and also affected CA3 (KA 21 days: n = 6 mice, Figure 8F).
In the ipsilateral intermediate and temporal hippocampus NPY
expression in cell bodies was preserved in the hilus and CA region
in all mice (Figures 8G,H). Remarkably, NPY-positive cell bodies
were visible in the hilus at sites where GCD was present (i.e., septal
to the transition zone, Figures 8H,I), which is in contrast to PV.
At 21 days the staining of mossy ﬁbers has substantially changed
compared to 2 days: in the septal hippocampus NPY-labeled
mossy ﬁbers were observed throughout the granule cell layer and
molecular layer and at a small spot in CA3/CA2 (Figures 8F–H),
resembling the spatial pattern of Timm staining (Bouilleret et al.,
1999) and thus most likely reﬂects mossy ﬁber sprouting. This
pattern was present at all positions where GCD occurred and
extended even slightly beyond the transition zone (Figures 8G,H).
Toward the temporal pole NPY labeling in mossy ﬁbers was
enhanced in the hilus and CA3, indicating that mossy ﬁber
sprouting and normal mossy ﬁber localization overlapped (n = 6,
Figures 8H,J).
DISCUSSION
In the current study we compared the intrahippocampal spread of
KA-induced SE with the spatial pattern of interneuron loss along
the septotemporal axis of the hippocampus. We show that in the
ipsilateral septal hippocampus most GAD67 mRNA-expressing
interneurons were lost already at 2 days after KA injection except
for a small population of interneurons in CA3 including PV- and
NPY-positive cells. Cell loss extended to the intermediate hip-
pocampus already at 2 days, but progressed further toward the
intermediate hippocampus and to CA3 until 21 days. In the inter-
mediate hippocampus we observed a differential vulnerability of
the different interneuron populations: PV-expressing cells were
lost at much more temporally located areas than NPY-expressing
cells. In addition to the loss of interneurons, we show that GAD67
mRNA was exclusively upregulated in dispersed granule cells,
whereas upregulation of NPY expression occurred in ipsilateral
septal granule cells and in mossy ﬁbers throughout the hippocam-
pus, most likely representing a compensatory mechanism to the
loss of inhibition.
INTERNEURONS WERE LOST BEYOND THE SCLEROTIC AREAS
In our previous study, we demonstrated that recurrent epilepti-
form activity is not strongest in the most sclerotic areas of the
septal hippocampus, but instead in the intermediate hippocam-
pus, which shows only minor histological changes (Häussler et al.,
2012). Here, we thus analyzed how inhibition could contribute to
differential strength of epileptiform activity bymapping the distri-
bution of interneurons along the entire septotemporal axis. To this
end, we quantiﬁed the distribution of GAD67 mRNA-expressing
cells and PV-expressing interneurons along the septotemporal axis
of the hippocampus. In our quantiﬁcation PV-positive interneu-
rons make up for 8–13% of the total density of GAD67-positive
interneurons in the hilus and 12–15% in the whole hippocampus
which is lower thanwhat has been shown in the literature (14–20%
in the hilus, 20–24% in the hippocampus; Freund and Buzsaki,
1996). A higher yield and better signal-to-noise ratio in in situ
FIGURE 8 | NPY staining pattern changes between 2 and 21 days after
KA injection. (A–J) Representative sections of an immunocytochemical
staining for NPY (red) with DAPI counterstaining (blue) at 21 days after KA
injection. (A–E) Contralateral hippocampus, septal (A), intermediate (B) and
temporal hippocampus (C–E). Upregulation of NPY in the CA region was no
longer visible but NPY-expressing interneurons were distributed comparable
to controls. NPY was upregulated in the mossy ﬁbers at all septotemporal
levels (white and yellow box in C, enlarged in D and E, respectively). Some
terminals of NPY-positive ﬁbers were seen in the inner molecular layer of
the septal hippocampus (arrow inA). (F–J) Ipsilateral hippocampus. (F) In
the septal hippocampus most NPY-positive interneurons were lost.
(Continued)
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FIGURE 8 | Continued
Instead, NPY was strongly upregulated in mossy ﬁbers. Note that mossy
ﬁbers had sprouted into the dispersed granule cell layer and molecular layer
(white arrow). In addition a termination zone in distal CA3/CA2 was visible
(yellow arrow). In contrast to the earlier time point, granule cell bodies were
not strongly NPY-positive. (G) In the intermediate hippocampus NPY-positive
interneurons were preserved in the ventral parts of the section, however,
starting from areas located more septal than the transition zone from GCD
to normal granule cell layer width (arrows). In the dorsal part of the section a
pattern of mossy ﬁber sprouting comparable to the septal hippocampus
occurred whereas in the ventral parts NPY was still upregulated in mossy
ﬁbers but at their normal position. Note the overlap of sprouted and normal
mossy ﬁbers. (H) In the temporal hippocampus NPY-positive interneurons
were preserved slightly dorsal to the transition zone (arrows), where GCD
was still visible and mossy ﬁber sprouting occurred (white box, enlarged in
I). Preservation of NPY-positive cells was also seen more ventrally where
enhanced NPY expression was seen in mossy ﬁbers in the hilus (yellow
box, enlarged in J). Scale bars: 200 μm; D, E, I, J, 50 μm.
hybridization for GAD67 mRNA compared to immunocytochem-
istry for PV expression might lead to this underestimation of the
relation. However, as the relation is comparable for controls and
KA-injected mice for all four positions, it does not inﬂuence our
results on changes in the distribution of PV-positive cells in TLE.
In addition to the nearly complete loss of GAD67 mRNA-
expressing interneurons in the septal hippocampus at 21 days after
KA injection, which has been previously shown (Bouilleret et al.,
2000a,b), our analysis revealed that the loss of interneurons is not
restricted to the sclerotic area, but extends to the intermediate
hippocampus. More precisely, the loss of interneurons extends
even beyond the transition zone from GCD to normal granule cell
layer width. In particular interneurons expressing PV showed a
high vulnerability: PV-positive somata, as well as the dense PV-
positive axon plexus were also only visible at sites temporal to this
transition zone.
We are aware that the loss of PV expression might not be equiv-
alent to the death of these interneurons and might reﬂect only a
transient down-regulation of PV synthesis as suggested previously
(Sloviter et al., 1991; Scotti et al., 1997; Wittner et al., 2001), or a
transient reduction of inhibitiory function followed by structural
or functional reconstruction, as shown in other epilepsy models
(Houser and Esclapez, 1996; Hellier et al., 1999; Bernard et al.,
2000; Holtkamp et al., 2005; Sloviter et al., 2006). However, given
the loss of GAD67 mRNA expression at the same sites and neu-
ronal death mainly in the hilus, close to the granule cell layer
and in the CA region, as shown by Fluoro-Jade B staining, it is
highly likely that the loss of PV expression reﬂects the death of
these inhibitory interneurons instead of a transient loss of func-
tion. This is supported by a recent study in which granule cell
responses upon perforant path stimulation were recorded in vivo
in intrahippocampally KA-injected mice: granule cells showed
oscillatory responses and reduced paired pulse inhibition already
at 3 days after KA and the number of population spikes was even
increased at 21 days after KA while paired pulse inhibition did
not recover (Rougier et al., 2005), indicating the loss of inhibitory
neurons.
Conﬂicting results on vulnerability of PV-expressing interneu-
rons in human TLE and animal models exist in the literature
(de Lanerolle et al., 1989; Sloviter et al., 1991; Zhu et al., 1997;
van Vliet et al., 2004; Andrioli et al., 2007; Wyeth et al., 2010;
Kuruba et al., 2011). Our data show that the almost complete loss
of PV-positive interneurons explains only partially the total loss
of GAD67 mRNA-positive interneurons and preliminary analyses
revealed that this difference is not fully explained by the loss of
NPY-expressing interneurons. This is in agreement with previous
studies, in which, additionally, the loss of somatostatin-positive
interneurons (Bouilleret et al., 2000b; Dugladze et al., 2007),
calretinin- and calbindin-positive interneurons has been shown
in the septal hippocampus of KA-injected mice (Bouilleret et al.,
2000a). Mapping the contribution of these additional interneuron
subtypes to total interneuron loss along the septotemporal axis is
a goal for future studies.
The nearly complete loss of interneurons in the septal hip-
pocampus in our model might be due to the strong sclerosis in
this area and may represent an overestimation of what happens in
human TLE. However, a correlation between the loss of pyramidal
cells and the loss of interneurons in the hilus and in CA1 has
also been shown in human TLE (Thom et al., 2012). In addi-
tion, that study showed that gradients of cell loss of principal cells
and interneurons occur along the human longitudinal hippocam-
pal axis in TLE with a trend toward stronger loss in the anterior
and intermediate hippocampus. These data strongly support the
transferability of our animal model to the human pathology.
Furthermore, the expansion of cell loss toward the intermedi-
ate hippocampus and toward CA3 between 2 and 21 days in our
study indicates that interneuron loss cannot be completely due
to excitotoxicity of KA but that also SE and recurrent epilepti-
form activity have a destructive effect on interneurons (Mello and
Covolan, 1996) and lead to progression of the disease as suggested
by others (van Vliet et al., 2004).
Since the lack of PV-expression has been associated with
increased seizure susceptibility (Schwaller et al., 2004), it seems
likely that the strong reduction of perisomatically inhibiting PV-
positive interneurons in the septal and intermediate hippocampus
indeed contributes to the increased epileptogenicity in these
regions. In the septal hippocampus, where dispersed granule cells
show diminished excitability (Young et al., 2009), this might result
in weaker epileptiform activity than at sites adjacent to the tran-
sition zone, matching the results of our previous study (Häussler
et al., 2012). Yet, hypothesizing such an effect only from our cur-
rent results is difﬁcult due to the complex function of perisomatic
and dendritic inhibition in the dentate gyrus since it actually
might have a depolarizing effect due to the low resting poten-
tial of granule cells (Sauer et al., 2012). Our data thus highlight the
importance of studying in detail the interaction between granule
cells and interneurons in the structurally preserved intermediate
hippocampus.
DIFFERENTIAL UPREGULATION OF NPY AND GAD67 EXPRESSION
The loss of NPY-expressing interneurons in the ipsilateral septal
hippocampus at 2 days after KA, the slight progress of cell loss
until 21 days, as well as the transient upregulation of NPY in
septal granule cells only at 2 days are in agreement with previ-
ous results (Makiura et al., 1999). However, the upregulation of
NPY in interneurons in the contralateral CA1 region at 2 days
after KA has not been described in this model previously. The
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differing pattern of NPY expression in the ipsi- and contralateral
hippocampus in particular at 2 days suggests that it is driven by
differential activation during SE. In fact, we found that SE activity
was strong in the contralateral septal hippocampus but weak in
the ipsilateral septal hippocampus, most likely due to a depolar-
ization block in granule cells close to the injection site (Le Duigou
et al., 2005). Accordingly, systemic KA injection in rats has shown
that strong convulsions cause upregulation of NPY in granule cells
while slight convulsions induce NPY upregulation in interneurons
(Gruber et al., 1994). Furthermore, several studies demonstrated
that high doses of glutamate agonists injected into one hippocam-
pus provoke upregulation of NPY in contralateral interneurons
(Gruber et al., 1994; Schwarzer and Sperk, 1998), whereas subneu-
rodegenerative doses cause upregulation of NPY only ipsilaterally.
Factors regulating NPY expression include interleukins (Barnea
et al., 2001) or BDNF (Nawa et al., 1994) and, indeed, the increased
expression of BDNF observed at 2 days after intrahippocampal
KA injection in mice was stronger in the ipsilateral than in the
contralateral granule cell layer (Heinrich et al., 2011).
In addition to the short-time effect, characterized by a transient
upregulation of NPY in ipsilateral granule cells and contralateral
interneurons, we observed an additional long-term effect charac-
terized by upregulation of NPY in ipsi- and contra-lateral mossy
ﬁbers. This is already visible at 2 days but augments in the follow-
ing, which is salient in mossy ﬁbers of the ipsilateral intermediate
and temporal hippocampus showing strong NPY labeling only
at the late time point. A comparable augmentation of NPY with
time after the initial insult has also been observed in pilocarpine-
injected mice (Borges et al., 2003). The long-term effect might
either be induced by gene expression patterns different from short-
term effects, or, more likely by epileptiform activity, since the
so-called silent period after intrahippocampal KA injection is not
fully silent but characterized by isolated high amplitude spikes
or short groups of epileptiform spikes at all septotemporal levels
of both hippocampi (Arabadzisz et al., 2005; Meier et al., 2007;
Häussler et al., 2012).
Upregulation of NPY is considered as endogenous antiepileptic
mechanism protecting the brain against seizure-related damage
(Klapstein and Colmers, 1997; Vezzani et al., 2002). Our study
shows that this compensatory effect is present on the whole sep-
totemporal extent of both hippocampi, yet, the different patterns
septal and temporal to the transition zone reﬂect different struc-
tural changes: in the septal hippocampus excitation is augmented
by recurrent mossy ﬁber sprouting (Cronin et al., 1992) and this
recurrent excitation is possibly attenuated by NPY in sprouted
mossy ﬁber terminals. There is evidence in pilocarpine-injected
mice that sprouted mossy ﬁbers release NPY acting via the Y2
receptors which induce an inhibitory effect despite the recurrence
(Nadler et al., 2007). In temporal areas and in the contralat-
eral hippocampus CA3 pyramidal cells are preserved and since
the intrinsic recurrent connectivity renders this region strongly
excitable, mossy ﬁber input needs to be attenuated there. Inter-
estingly, in the intermediate hippocampus both mechanisms are
observable: mossy ﬁbers still sprout into the molecular layer at
sites with normal granule cell layer width but due to the preser-
vation of CA3 the mossy ﬁber output to CA3 also seems to be
compensated.
A second, possibly compensatory mechanism is the upregula-
tion of GAD67 in granule cells which mainly occurs in the septal
and intermediate ipsilateral hippocampus at 2 days after KA and is
restricted to dispersed granule cells at 21 days after KA. This is in
agreement with results in human TLE where strong upregulation
of GAD67 has been shown in granule cells (Sperk et al., 2012) and
with other animal models (Schwarzer and Sperk, 1995; Ramirez
and Gutierrez, 2001). It has been shown that mossy ﬁber boutons
release glutamate and GABA under healthy conditions (Beltrán
and Gutiérrez, 2012) and that functional GABAergic transmis-
sion occurs in mossy ﬁbers of hippocampal slices from rats after
kindling (Gutierrez and Heinemann, 2001), suggesting that the
upregulation of GAD67 in granule cells in our mice also leads
to locally increased GABAergic transmission. To clarify whether
this transmission has an effect compensating hyperexcitability
requires experiments in slices from different septotemporal lev-
els since the inﬂuence on CA3 pyramidal cells and, via mossy ﬁber
sprouting-induced backpropagation, on other granule cells might
be different.
DOES THE INTERMEDIATE HIPPOCAMPUS CONSTITUTE AN
EPILEPTOGENIC NETWORK?
Our study indicates that the intermediate hippocampus com-
prises multifaceted changes including the transition from GCD to
normal granule cell layer width, differential vulnerability of PV-
and NPY-expressing cells, and recovery of neurogenesis (Häus-
sler et al., 2012). All these changes might be functionally linked.
GCD is caused by migrating granule cells which lose their posi-
tional information through the loss and functional inactivation of
Reelin (Haas et al., 2002; Heinrich et al., 2006; Müller et al., 2009;
Tinnes et al., 2011) which normally acts as a position signal during
development and in the adult. In the healthy hippocampus, Reelin
is expressed by interneurons in the hilus, at the hippocampal ﬁs-
sure and in stratum oriens of the CA region (Pesold et al., 1998).
In particular, the hilar interneurons are lost after KA injection as
shown in our study. Interestingly, Reelin-expressing interneurons
co-express NPY or somatostatin, but not PV (Pesold et al., 1999).
The loss of PV-expressing interneurons in our study extended
beyond GCD, but NPY-expressing cells were visible slightly more
septally indicating that the extent of NPY cell loss might inﬂuence
the septotemporal extent of GCD through expression gradients of
Reelin. Another important fact is that NPY promotes hippocam-
pal neurogenesis (Howell et al., 2003, 2005; Decressac et al., 2011)
and we previously showed differential regulation of neurogene-
sis with respect to strength of the initial SE: neurogenesis is lost
in the septal hippocampus and only present in the intermediate
and temporal hippocampus (Häussler et al., 2012). In fact, in the
intermediate, temporal and contralateral hippocampus neuroge-
nesis is strongly increased compared to controls which might be
stimulated by the expression of NPY in non-sprouted mossy ﬁbers
together with the expression of NPY in surviving interneurons.
Does the transition zone have a functional role? In our previous
study, we have shown that epileptiform activity was not strongest
at sites where hippocampal sclerosis was most pronounced but,
instead, in the adjacent area of the transition zone where neuro-
genesis reappeared. Neurogenesis, together with the reduction of
inhibitory interneurons in this region, might comprise a network
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with disturbed excitation-inhibition balance and high epilepto-
genicity. The functional consequences of such gradual changes
might be transferred to human TLE in which gradients of cell
loss along the longitudinal hippocampal axis have been shown
(Thom et al., 2012). In addition, our precise quantitative analysis
of interneuron densities and neurogenesis in the whole hippocam-
pus paves a way for modeling studies on the epileptogenicity of
small shifts in network balance.
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